» Articles » PMID: 22449713

Embryonic Stem Cells Improve Cardiac Function in Doxorubicin-induced Cardiomyopathy Mediated Through Multiple Mechanisms

Overview
Journal Cell Transplant
Date 2012 Mar 28
PMID 22449713
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Doxorubicin (DOX) is an effective antineoplastic agent used for the treatment of a variety of cancers. Unfortunately, its use is limited as this drug induces cardiotoxicity and heart failure as a side effect. There is no report that describes whether transplanted embryonic stem (ES) cells or their conditioned medium (CM) in DOX-induced cardiomyopathy (DIC) can repair and regenerate myocardium. Therefore, we transplanted ES cells or CM in DIC to examine apoptosis, fibrosis, cytoplasmic vacuolization, and myofibrillar loss and their associated Akt and ERK pathway. Moreover, we also determined activation of endogenous c-kit(+ve) cardiac stem cells (CSCs), levels of HGF and IGF-1, growth factors required for c-kit cell activation, and their differentiation into cardiac myocytes, which also contributes in cardiac regeneration and improved heart function. We generated DIC in C57Bl/6 mice (cumulative dose of DOX 12 mg/kg body weight, IP), and animals were treated with ES cells, CM, or cell culture medium in controls. Two weeks post-DIC, ES cells or CM transplanted hearts showed a significant (p < 0.05) decrease in cardiac apoptotic nuclei and their regulation with Akt and ERK pathway. Cardiac fibrosis observed in the ES cell or CM groups was significantly less compared with DOX and cell culture medium groups (p < 0.05). Next, cytoplasmic vacuolization and myofibrillar loss was reduced (p < 0.05) following treatment with ES cells or CM. Moreover, our data also demonstrated increased levels of c-kit(+ve) CSCs in ES cells or CM hearts and differentiated cardiac myocytes from these CSCs, suggesting endogenous cardiac regeneration. Importantly, the levels of HFG and IGF-1 were significantly increased in ES cells or CM transplanted hearts. In conclusion, we reported that transplanted ES cells or CM in DIC hearts significantly decreases various adverse pathological mechanisms as well as enhances cardiac regeneration that effectively contributes to improved heart function.

Citing Articles

Intrapericardial injection of hydrogels with ASC and their secretome to treat dilated cardiomyopathies.

Liguori T, Liguori G, Sinkunas V, Correia C, Dos Santos Coutinho E Silva R, Zanoni F Sci Rep. 2025; 15(1):3529.

PMID: 39875493 PMC: 11775170. DOI: 10.1038/s41598-025-87939-z.


In Vitro Models of Cardiovascular Disease: Embryoid Bodies, Organoids and Everything in Between.

Stougiannou T, Christodoulou K, Karangelis D Biomedicines. 2025; 12(12.

PMID: 39767621 PMC: 11726960. DOI: 10.3390/biomedicines12122714.


Stem cell-based therapy for fibrotic diseases: mechanisms and pathways.

Taherian M, Bayati P, Mojtabavi N Stem Cell Res Ther. 2024; 15(1):170.

PMID: 38886859 PMC: 11184790. DOI: 10.1186/s13287-024-03782-5.


Therapeutic potential of extracellular vesicles derived from cardiac progenitor cells in rodent models of chemotherapy-induced cardiomyopathy.

Desgres M, Lima Correa B, Petrusca L, Autret G, Pezzana C, Marigny C Front Cardiovasc Med. 2023; 10:1206279.

PMID: 37485274 PMC: 10360184. DOI: 10.3389/fcvm.2023.1206279.


Synergistic cardioprotective effects of melatonin and deferoxamine through the improvement of ferritinophagy in doxorubicin-induced acute cardiotoxicity.

Hanna M, Seddiek H, Aboulhoda B, Morcos G, Akabawy A, Elbaset M Front Physiol. 2022; 13:1050598.

PMID: 36531171 PMC: 9748574. DOI: 10.3389/fphys.2022.1050598.


References
1.
Kumar D, Kirshenbaum L, Li T, Danelisen I, Singal P . Apoptosis in adriamycin cardiomyopathy and its modulation by probucol. Antioxid Redox Signal. 2001; 3(1):135-45. DOI: 10.1089/152308601750100641. View

2.
Singla D, Singla R, McDonald D . Factors released from embryonic stem cells inhibit apoptosis in H9c2 cells through PI3K/Akt but not ERK pathway. Am J Physiol Heart Circ Physiol. 2008; 295(2):H907-13. PMC: 2519202. DOI: 10.1152/ajpheart.00279.2008. View

3.
Haider H, Ashraf M . Bone marrow cell transplantation in clinical perspective. J Mol Cell Cardiol. 2005; 38(2):225-35. DOI: 10.1016/j.yjmcc.2004.12.005. View

4.
Fujio Y, Nguyen T, Wencker D, Kitsis R, Walsh K . Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation. 2000; 101(6):660-7. PMC: 3627349. DOI: 10.1161/01.cir.101.6.660. View

5.
Garbade J, Dhein S, Lipinski C, Aupperle H, Arsalan M, Borger M . Bone marrow-derived stem cells attenuate impaired contractility and enhance capillary density in a rabbit model of Doxorubicin-induced failing hearts. J Card Surg. 2009; 24(5):591-9. DOI: 10.1111/j.1540-8191.2009.00844.x. View